{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:43:14Z","timestamp":1791567794358,"version":"4.3.4"},"reference-count":150,"publisher":"Ubiquity Press, Ltd.","issue":"1","funder":[{"name":"Paul Ainsworth Family Foundation","award":["2023126"],"award-info":[{"award-number":["2023126"]}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"crossref","award":["2023126"],"award-info":[{"award-number":["2023126"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,8]]},"DOI":"10.5334\/tohm.835","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T07:34:36Z","timestamp":1704699276000},"source":"Crossref","is-referenced-by-count":12,"title":["Genetic Testing of Movements Disorders: A Review of Clinical Utility"],"prefix":"10.5334","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-7007","authenticated-orcid":false,"given":"Dennis","family":"Yeow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-319X","authenticated-orcid":false,"given":"Laura I.","family":"Rudaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-0228","authenticated-orcid":false,"given":"Sue-Faye","family":"Siow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0512-8989","authenticated-orcid":false,"given":"Ryan L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-6962","authenticated-orcid":false,"given":"Kishore R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"7","key":"key20240108073431_B1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0039-1688446","article-title":"Next-generation sequencing and emerging technologies","volume":"45","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"key20240108073431_B2","article-title":"Monogenic Parkinson\u2019s disease: genotype, phenotype, pathophysiology, and genetic testing","volume":"13","year":"2022","journal-title":"Genes (Basel)"},{"issue":"4","key":"key20240108073431_B3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10048-021-00656-3","article-title":"Milestones in genetics of cerebellar ataxias","volume":"22","year":"2021","journal-title":"Neurogenetics"},{"issue":"5","key":"key20240108073431_B4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mds.28982","article-title":"Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society Task Force \u2013 an update","volume":"37","year":"2022","journal-title":"Mov Disord"},{"issue":"1","key":"key20240108073431_B5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40246-023-00524-1","article-title":"Determining the utility of diagnostic genomics: a conceptual framework","volume":"17","year":"2023","journal-title":"Hum Genomics"},{"issue":"3","key":"key20240108073431_B6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40271-021-00558-4","article-title":"Perceived utility of genomic sequencing: qualitative analysis and synthesis of a conceptual model to inform patient-centered instrument development","volume":"15","year":"2022","journal-title":"Patient"},{"issue":"1","key":"key20240108073431_B7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41436-019-0620-0","article-title":"The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testing","volume":"22","year":"2020","journal-title":"Genet Med"},{"key":"key20240108073431_B8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-genom-083115-022348","article-title":"Defining the clinical value of a genomic diagnosis in the era of next-generation sequencing","volume":"17","year":"2016","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"key20240108073431_B9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2020.02.015","article-title":"New generation genetic testing entering the clinic","volume":"73","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"key20240108073431_B10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pediatrneurol.2022.04.004","article-title":"Inherited ataxias in children","volume":"131","year":"2022","journal-title":"Pediatr Neurol"},{"issue":"2","key":"key20240108073431_B11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","year":"2020","journal-title":"Lancet Neurol"},{"issue":"Pt 7","key":"key20240108073431_B12","first-page":"2017","article-title":"The genetics of dystonia: new twists in an old tale","volume":"136","year":"2013","journal-title":"Brain"},{"issue":"10","key":"key20240108073431_B13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/jnnp-2021-328120","article-title":"A novel diagnostic approach for patients with adult-onset dystonia","volume":"93","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"key20240108073431_B14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/practneurol-2018-002096","article-title":"Diagnosis and management of progressive ataxia in adults","volume":"19","year":"2019","journal-title":"Pract Neurol"},{"issue":"11","key":"key20240108073431_B15","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1474-4422(20)30312-4","article-title":"Monogenic variants in dystonia: an exome-wide sequencing study","volume":"19","year":"2020","journal-title":"Lancet Neurol"},{"issue":"3","key":"key20240108073431_B16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jmoldx.2021.12.003","article-title":"A clinical and integrated genetic study of isolated and combined dystonia in Taiwan","volume":"24","year":"2022","journal-title":"J Mol Diagn"},{"issue":"4","key":"key20240108073431_B17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/jnnp-2016-314863","article-title":"Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients","volume":"88","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 10","key":"key20240108073431_B18","first-page":"3106","article-title":"Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model","volume":"136","year":"2013","journal-title":"Brain"},{"issue":"1","key":"key20240108073431_B19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41531-023-00518-9","article-title":"The genetic spectrum of a cohort of patients clinically diagnosed as Parkinson\u2019s disease in mainland China","volume":"9","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"key20240108073431_B20","doi-asserted-by":"crossref","first-page":"849462","DOI":"10.3389\/fnagi.2022.849462","article-title":"Genetic analysis of patients with early-onset Parkinson\u2019s disease in eastern China","volume":"14","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"key20240108073431_B21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(21)00462-2","article-title":"Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study","volume":"21","year":"2022","journal-title":"Lancet Neurol"},{"issue":"4","key":"key20240108073431_B22","article-title":"Integrating genetic structural variations and whole-genome sequencing into clinical neurology","volume":"8","year":"2022","journal-title":"Neurol Genet"},{"issue":"4","key":"key20240108073431_B23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12311-019-01038-0","article-title":"Increased diagnostic yield of spastic paraplegia with or without cerebellar ataxia through whole-genome sequencing","volume":"18","year":"2019","journal-title":"Cerebellum"},{"key":"key20240108073431_B24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2019.11.004","article-title":"Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypes","volume":"69","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"key20240108073431_B25","first-page":"e1770","article-title":"Diagnostic yield of whole genome sequencing after nondiagnostic exome sequencing or gene panel in developmental and epileptic encephalopathies","volume":"96","year":"2021","journal-title":"Neurology"},{"issue":"10","key":"key20240108073431_B26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41431-022-01162-2","article-title":"Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis","volume":"30","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"key20240108073431_B27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/humu.23946","article-title":"A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders","volume":"41","year":"2020","journal-title":"Hum Mutat"},{"key":"key20240108073431_B28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2021.02.013","article-title":"Clinically relevant copy-number variants in exome sequencing data of patients with dystonia","volume":"84","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"key20240108073431_B29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/mds.26937","article-title":"A post hoc study on gene panel analysis for the diagnosis of dystonia","volume":"32","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"key20240108073431_B30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ana.26636","article-title":"Differences in survival across monogenic forms of Parkinson\u2019s disease","volume":"94","year":"2023","journal-title":"Ann Neurol"},{"issue":"3","key":"key20240108073431_B31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/humu.22016","article-title":"Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study","volume":"33","year":"2012","journal-title":"Hum Mutat"},{"issue":"1","key":"key20240108073431_B32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajhg.2021.12.002","article-title":"Longer CAG repeat length is associated with shorter survival after disease onset in Huntington disease","volume":"109","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"10","key":"key20240108073431_B33","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1093\/brain\/awaa263","article-title":"A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families","volume":"143","year":"2020","journal-title":"Brain"},{"issue":"1","key":"key20240108073431_B34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10048-013-0385-6","article-title":"Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures","volume":"15","year":"2014","journal-title":"Neurogenetics"},{"issue":"6","key":"key20240108073431_B35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","article-title":"Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease","volume":"104","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"9","key":"key20240108073431_B36","article-title":"Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing","volume":"8","year":"2022","journal-title":"Sci Adv"},{"issue":"3","key":"key20240108073431_B37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awac160","article-title":"Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset","volume":"146","year":"2023","journal-title":"Brain"},{"issue":"3","key":"key20240108073431_B38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2017.4206","article-title":"Association of polygenic risk score with cognitive decline and motor progression in Parkinson disease","volume":"75","year":"2018","journal-title":"JAMA Neurol"},{"issue":"10","key":"key20240108073431_B39","article-title":"Polygenic risk scores contribute to personalized medicine of Parkinson\u2019s disease","volume":"11","year":"2021","journal-title":"J Pers Med"},{"issue":"5","key":"key20240108073431_B40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s10897-018-0239-3","article-title":"Parkinson\u2019s disease: patients\u2019 knowledge, attitudes, and interest in genetic counseling","volume":"27","year":"2018","journal-title":"J Genet Couns"},{"issue":"1","key":"key20240108073431_B41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10897-013-9618-y","article-title":"Knowledge of and interest in genetic results among Parkinson disease patients and caregivers","volume":"23","year":"2014","journal-title":"J Genet Couns"},{"issue":"4","key":"key20240108073431_B42","article-title":"Genome sequencing in the Parkinson disease clinic","volume":"8","year":"2022","journal-title":"Neurol Genet"},{"key":"key20240108073431_B43","doi-asserted-by":"crossref","first-page":"659805","DOI":"10.3389\/fneur.2021.659805","article-title":"Treatable hyperkinetic movement disorders not to be missed","volume":"12","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"key20240108073431_B44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mds.27140","article-title":"Treatable inherited rare movement disorders","volume":"33","year":"2018","journal-title":"Mov Disord"},{"issue":"5","key":"key20240108073431_B45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mds.27568","article-title":"Movement disorders in treatable inborn errors of metabolism","volume":"34","year":"2019","journal-title":"Mov Disord"},{"issue":"3","key":"key20240108073431_B46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.14802\/jmd.22069","article-title":"Treatable ataxias: how to find the needle in the haystack?","volume":"15","year":"2022","journal-title":"J Mov Disord"},{"issue":"10","key":"key20240108073431_B47","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1093\/brain\/awad157","article-title":"GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response","volume":"146","year":"2023","journal-title":"Brain"},{"issue":"2","key":"key20240108073431_B48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2207406","article-title":"Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia","volume":"388","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"key20240108073431_B49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/L19-0038","article-title":"Caffeine and the dyskinesia related to mutations in the ADCY5 gene","volume":"171","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"key20240108073431_B50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study)","volume":"89","year":"2021","journal-title":"Ann Neurol"},{"issue":"3","key":"key20240108073431_B51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/1570159X21666221229154830","article-title":"Pharmacogenomics-a new frontier for individualized treatment of Parkinson\u2019s disease","volume":"21","year":"2023","journal-title":"Curr Neuropharmacol"},{"key":"key20240108073431_B52","doi-asserted-by":"crossref","first-page":"895430","DOI":"10.3389\/fnagi.2022.895430","article-title":"The role of genetic data in selecting device-aided therapies in patients with advanced Parkinson\u2019s disease: a mini-review","volume":"14","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"key20240108073431_B53","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.26302","article-title":"Parkinson disease and subthalamic nucleus deep brain stimulation: cognitive effects in GBA mutation carriers","volume":"91","year":"2022","journal-title":"Ann Neurol"},{"key":"key20240108073431_B54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2020.04.002","article-title":"Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson\u2019s disease patients with GBA mutations","volume":"76","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"key20240108073431_B55","article-title":"Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20240108073431_B56","first-page":"630391","article-title":"Pallidal deep brain stimulation for monogenic dystonia: the effect of gene on outcome","volume":"11","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"key20240108073431_B57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mdc3.13113","article-title":"Deep brain stimulation in dystonia: disentangling heterogeneity","volume":"8","year":"2021","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"key20240108073431_B58","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jnnp-2019-322169","article-title":"Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis","volume":"91","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20240108073431_B59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parkreldis.2017.09.008","article-title":"Failure of pallidal deep brain stimulation in DYT12-ATP1A3 dystonia","volume":"45","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"key20240108073431_B60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mdc3.12559","article-title":"Failure of sequential pallidal and motor thalamus DBS for rapid-onset dystonia-parkinsonism (DYT12)","volume":"5","year":"2018","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"key20240108073431_B61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/mdc3.12605","article-title":"Atypical presentation of rapid-onset dystonia-parkinsonism (DYT12) unresponsive to deep brain stimulation of the subthalamic nucleus","volume":"5","year":"2018","journal-title":"Mov Disord Clin Pract"},{"issue":"5","key":"key20240108073431_B62","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.brs.2023.08.021","article-title":"Centromedian-parafascicular complex deep brain stimulation improves motor symptoms in rapid onset dystonia-parkinsonism (DYT12-ATP1A3)","volume":"16","year":"2023","journal-title":"Brain Stimul"},{"key":"key20240108073431_B63","first-page":"9","article-title":"Generalized dystonia and paroxysmal Dystonic attacks due to a novel ATP1A3 variant","year":"2019","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"5","key":"key20240108073431_B64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1468-1331.2001.00273.x","article-title":"Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency","volume":"8","year":"2001","journal-title":"Eur J Neurol"},{"issue":"2","key":"key20240108073431_B65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mds.20660","article-title":"Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet","volume":"21","year":"2006","journal-title":"Mov Disord"},{"issue":"3","key":"key20240108073431_B66","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00415-014-7240-z","article-title":"GLUT1 deficiency syndrome into adulthood: a follow-up study","volume":"261","year":"2014","journal-title":"J Neurol"},{"key":"key20240108073431_B67","doi-asserted-by":"crossref","first-page":"648532","DOI":"10.3389\/fneur.2021.648532","article-title":"Gene therapy in movement disorders: a systematic review of ongoing and completed clinical trials","volume":"12","year":"2021","journal-title":"Front Neurol"},{"issue":"2","key":"key20240108073431_B68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","year":"2022","journal-title":"Mol Ther"},{"issue":"5","key":"key20240108073431_B69","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"key20240108073431_B70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.parkreldis.2012.03.020","article-title":"New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism","volume":"18","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"key20240108073431_B71","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/archneurol.2012.574","article-title":"Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs","volume":"69","year":"2012","journal-title":"Arch Neurol"},{"issue":"10","key":"key20240108073431_B72","article-title":"RFC1 expansions can mimic hereditary sensory neuropathy with cough and Sjogren syndrome","volume":"143","year":"2020","journal-title":"Brain"},{"issue":"4","key":"key20240108073431_B73","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4103\/0028-3886.325344","article-title":"A case of HSP carrying c.1537\u201311A > G mutation of the SPAST gene presented as stiff-person syndrome","volume":"69","year":"2021","journal-title":"Neurol India"},{"issue":"1","key":"key20240108073431_B74","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00415-022-11382-7","article-title":"Sjogren syndrome and RFC1-CANVAS sensory ganglionopathy: co-occurrence or misdiagnosis?","volume":"270","year":"2023","journal-title":"J Neurol"},{"issue":"1","key":"key20240108073431_B75","doi-asserted-by":"crossref","first-page":"17801","DOI":"10.1038\/s41598-023-45011-8","article-title":"CANVAS-related RFC1 mutations in patients with immune-mediated neuropathy","volume":"13","year":"2023","journal-title":"Sci Rep"},{"issue":"9","key":"key20240108073431_B76","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1007\/s10072-022-06145-1","article-title":"Multiple sclerosis in patients with hereditary spastic paraplegia: a case report and systematic review","volume":"43","year":"2022","journal-title":"Neurol Sci"},{"issue":"1","key":"key20240108073431_B77","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-021-01688-6","article-title":"Exome sequencing in paediatric patients with movement disorders","volume":"16","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"key20240108073431_B78","article-title":"Genetic landscape of pediatric movement disorders and management implications","volume":"4","year":"2018","journal-title":"Neurol Genet"},{"issue":"4","key":"key20240108073431_B79","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jmg-2022-108477","article-title":"Reproductive choices and intrafamilial communication in neurogenetic diseases with different self-estimated severities","volume":"60","year":"2023","journal-title":"J Med Genet"},{"issue":"5","key":"key20240108073431_B80","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jgc4.1415","article-title":"Between responsibility and desire: accounts of reproductive decisions from those at risk for or affected by late-onset neurological diseases","volume":"30","year":"2021","journal-title":"J Genet Couns"},{"issue":"2","key":"key20240108073431_B81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/cge.14345","article-title":"Genetic risk for Huntington disease and reproductive decision-making: a systematic review","volume":"104","year":"2023","journal-title":"Clin Genet"},{"issue":"1","key":"key20240108073431_B82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mdc3.12859","article-title":"Spinocerebellar ataxia patient perceptions regarding reproductive options","volume":"7","year":"2020","journal-title":"Mov Disord Clin Pract"},{"issue":"10154","key":"key20240108073431_B83","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(18)31868-3","article-title":"Mitochondrial donation: from test tube to clinic","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"key20240108073431_B84","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s10897-016-9951-z","article-title":"Impact of Huntington disease gene-positive status on pre-symptomatic young adults and recommendations for genetic counselors","volume":"25","year":"2016","journal-title":"J Genet Couns"},{"issue":"3","key":"key20240108073431_B85","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/thg.2020.51","article-title":"Human Genetics Society of Australasia position statement: predictive and presymptomatic genetic testing in adults and children","volume":"23","year":"2020","journal-title":"Twin Res Hum Genet"},{"issue":"5","key":"key20240108073431_B86","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jme.2002.001578","article-title":"The right not to know: an autonomy based approach","volume":"30","year":"2004","journal-title":"J Med Ethics"},{"issue":"4","key":"key20240108073431_B87","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaoncol.2021.6204","article-title":"Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: a comparative modeling analysis","volume":"8","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"key20240108073431_B88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cge.14401","article-title":"Motivations to learn genomic information are not exceptional: lessons from behavioral science","volume":"104","year":"2023","journal-title":"Clin Genet"},{"issue":"1","key":"key20240108073431_B89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41436-020-00949-2","article-title":"The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment","volume":"23","year":"2021","journal-title":"Genet Med"},{"issue":"12","key":"key20240108073431_B90","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1038\/s41436-019-0583-1","article-title":"The value of diagnostic testing for parents of children with rare genetic diseases","volume":"21","year":"2019","journal-title":"Genet Med"},{"issue":"8","key":"key20240108073431_B91","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41436-020-0809-2","article-title":"The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments","volume":"22","year":"2020","journal-title":"Genet Med"},{"issue":"1","key":"key20240108073431_B92","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12920-016-0213-6","article-title":"Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users\u2019 views","volume":"9","year":"2016","journal-title":"BMC Med Genomics"},{"issue":"7","key":"key20240108073431_B93","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00439-013-1287-2","article-title":"Next-generation sequencing diagnostics for neurological diseases\/disorders: from a clinical perspective","volume":"132","year":"2013","journal-title":"Hum Genet"},{"key":"key20240108073431_B94","first-page":"155","volume-title":"Genomic Structural Variants in Nervous System Disorders","year":"2022"},{"issue":"9","key":"key20240108073431_B95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.0000000000012466","article-title":"Deciphering neurodegenerative diseases using long-read sequencing","volume":"97","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"key20240108073431_B96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajhg.2022.11.015","article-title":"An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50\/ATX-FGF14","volume":"110","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"4","key":"key20240108073431_B97","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41588-018-0067-2","article-title":"Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy","volume":"50","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"key20240108073431_B98","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1038\/s41467-019-12763-9","article-title":"Unstable TTTTA\/TTTCA expansions in MARCH6 are associated with familial adult myoclonic epilepsy type 3","volume":"10","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"key20240108073431_B99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12687-019-00434-7","article-title":"Patients\u2019 views on variants of uncertain significance across indications","volume":"11","year":"2020","journal-title":"J Community Genet"},{"issue":"9","key":"key20240108073431_B100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-018-1916-x","article-title":"Multiplexed assays of variant effects contribute to a growing genotype-phenotype atlas","volume":"137","year":"2018","journal-title":"Hum Genet"},{"issue":"6","key":"key20240108073431_B101","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s40291-020-00495-2","article-title":"The Impact of next-generation sequencing on the diagnosis, treatment, and prevention of hereditary neuromuscular disorders","volume":"24","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"key20240108073431_B102","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/mds.29442","article-title":"International genetic testing and counseling practices for Parkinson\u2019s disease","volume":"38","year":"2023","journal-title":"Mov Disord"},{"issue":"6","key":"key20240108073431_B103","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/ene.14826","article-title":"Worldwide barriers to genetic testing for movement disorders","volume":"28","year":"2021","journal-title":"Eur J Neurol"},{"issue":"3","key":"key20240108073431_B104","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41436-019-0684-x","article-title":"Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists","volume":"22","year":"2020","journal-title":"Genet Med"},{"issue":"4","key":"key20240108073431_B105","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/mds.28494","article-title":"GP2: the global Parkinson\u2019s genetics program","volume":"36","author":"Global Parkinson\u2019s Genetics Program","year":"2021","journal-title":"Mov Disord"},{"issue":"7","key":"key20240108073431_B106","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41576-022-00455-y","article-title":"Sociotechnical safeguards for genomic data privacy","volume":"23","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"2","key":"key20240108073431_B107","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/23808993.2019.1599685","article-title":"Privacy and ethical challenges in next-generation sequencing","volume":"4","year":"2019","journal-title":"Expert Rev Precis Med Drug Dev"},{"issue":"2","key":"key20240108073431_B108","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jns.2006.10.016","article-title":"Comparing knowledge and attitudes towards genetic testing in Parkinson\u2019s disease in an American and Asian population","volume":"252","year":"2007","journal-title":"J Neurol Sci"},{"issue":"5","key":"key20240108073431_B109","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMp1404776","article-title":"GINA, genetic discrimination, and genomic medicine","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"key":"key20240108073431_B110","article-title":"Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"key20240108073431_B111","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41431-019-0426-1","article-title":"Genetic discrimination by Australian insurance companies: a survey of consumer experiences","volume":"28","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"11 Suppl","key":"key20240108073431_B112","first-page":"S8","article-title":"Forensic genetics and ethical, legal and social implications beyond the clinic","volume":"36","year":"2004","journal-title":"Nat Genet"},{"key":"key20240108073431_B113","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fgene.2018.00624","article-title":"A systematic review of the psychological implications of genetic testing: a comparative analysis among cardiovascular, neurodegenerative and cancer diseases","volume":"9","year":"2018","journal-title":"Front Genet"},{"issue":"1","key":"key20240108073431_B114","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bmb\/ldu017","article-title":"Managing the ethical challenges of next-generation sequencing in genomic medicine","volume":"111","year":"2014","journal-title":"Br Med Bull"},{"issue":"8","key":"key20240108073431_B115","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/jmg-2022-109091","article-title":"A model for the return and referral of all clinically significant secondary findings of genomic sequencing","volume":"60","year":"2023","journal-title":"J Med Genet"},{"issue":"7","key":"key20240108073431_B116","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ejhg.2017.64","article-title":"Practices and views of neurologists regarding the use of whole-genome sequencing in clinical settings: a web-based survey","volume":"25","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"key20240108073431_B117","doi-asserted-by":"crossref","first-page":"117260","DOI":"10.1016\/j.jns.2020.117260","article-title":"The clinical utility of exome sequencing and extended bioinformatic analyses in adolescents and adults with a broad range of neurological phenotypes: an Australian perspective","volume":"420","year":"2021","journal-title":"J Neurol Sci"},{"issue":"11","key":"key20240108073431_B118","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41436-021-01250-6","article-title":"High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families","volume":"23","year":"2021","journal-title":"Genet Med"},{"issue":"16","key":"key20240108073431_B119","article-title":"NGS in hereditary ataxia: when rare becomes frequent","volume":"22","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"key20240108073431_B120","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4103\/0028-3886.349660","article-title":"Clinical and molecular spectrum of degenerative cerebellar ataxia: a single centre study","volume":"70","year":"2022","journal-title":"Neurol India"},{"issue":"3","key":"key20240108073431_B121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s13353-022-00701-3","article-title":"Application of a custom NGS gene panel revealed a high diagnostic utility for molecular testing of hereditary ataxias","volume":"63","year":"2022","journal-title":"J Appl Genet"},{"issue":"1","key":"key20240108073431_B122","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12311-021-01268-1","article-title":"Diagnostic yield of whole exome sequencing for adults with ataxia: a Brazilian perspective","volume":"21","year":"2022","journal-title":"Cerebellum"},{"key":"key20240108073431_B123","doi-asserted-by":"crossref","first-page":"105814","DOI":"10.1016\/j.parkreldis.2023.105814","article-title":"Whole exome sequencing and clinical investigation of young onset dystonia: what can we learn?","volume":"115","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"key20240108073431_B124","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/cge.14298","article-title":"Genetic spectrum and clinical features in a cohort of Chinese patients with isolated dystonia","volume":"103","year":"2023","journal-title":"Clin Genet"},{"issue":"1","key":"key20240108073431_B125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ane.13329","article-title":"Community-based genetic study of Parkinson\u2019s disease in Estonia","volume":"143","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"key20240108073431_B126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41531-022-00408-6","article-title":"A multicenter study of genetic testing for Parkinson\u2019s disease in the clinical setting","volume":"8","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"key20240108073431_B127","article-title":"Clinical and genetic analysis of Vietnamese patients diagnosed with early-onset Parkinson\u2019s disease","volume":"13","year":"2023","journal-title":"Brain Behav"},{"key":"key20240108073431_B128","doi-asserted-by":"crossref","first-page":"105399","DOI":"10.1016\/j.parkreldis.2023.105399","article-title":"Genetic study of early-onset Parkinson\u2019s disease in the Malaysian population","volume":"111","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"key20240108073431_B129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.410410318","article-title":"Use of desferrioxamine in the treatment of aceruloplasminemia","volume":"41","year":"1997","journal-title":"Ann Neurol"},{"issue":"3","key":"key20240108073431_B130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000008091","article-title":"A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma","volume":"42","year":"1999","journal-title":"Eur Neurol"},{"issue":"1","key":"key20240108073431_B131","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-016-0522-z","article-title":"Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency","volume":"12","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"key20240108073431_B132","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1212\/01.WNL.0000164000.75046.CC","article-title":"A novel TITF-1 mutation causes benign hereditary chorea with response to levodopa","volume":"64","year":"2005","journal-title":"Neurology"},{"issue":"26","key":"key20240108073431_B133","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","article-title":"Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"issue":"2","key":"key20240108073431_B134","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.28874","article-title":"Relationship of genotype, phenotype, and treatment in dopa-responsive dystonia: MDSGene review","volume":"37","year":"2022","journal-title":"Mov Disord"},{"issue":"2","key":"key20240108073431_B135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nurt.2007.01.014","article-title":"Episodic ataxia type 2","volume":"4","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"Pt 10","key":"key20240108073431_B136","first-page":"2484","article-title":"Primary episodic ataxias: diagnosis, pathogenesis and treatment","volume":"130","year":"2007","journal-title":"Brain"},{"issue":"2","key":"key20240108073431_B137","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-008-0813-1","article-title":"Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia\u2013a new metabolic disorder","volume":"31","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"22","key":"key20240108073431_B138","first-page":"360","article-title":"Niemann-Pick disease treatment: a systematic review of clinical trials","volume":"3","year":"2015","journal-title":"Ann Transl Med"},{"issue":"4","key":"key20240108073431_B139","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.47.4.1104-a","article-title":"Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine","volume":"47","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"key20240108073431_B140","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1542\/peds.2008-2027","article-title":"Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome","volume":"123","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"key20240108073431_B141","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ana.25059","article-title":"Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38","volume":"82","year":"2017","journal-title":"Ann Neurol"},{"issue":"4","key":"key20240108073431_B142","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9343(56)90066-3","article-title":"Penicillamine, a new oral therapy for Wilson\u2019s disease","volume":"21","year":"1956","journal-title":"Am J Med"},{"issue":"2\u20133","key":"key20240108073431_B143","first-page":"137","article-title":"Management of Wilson\u2019s disease with zinc sulphate. Experience in a series of 27 patients","volume":"77","year":"1987","journal-title":"J Neurol Sci"},{"issue":"3","key":"key20240108073431_B144","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/adc.52.3.209","article-title":"Long-term management of abetalipoproteinaemia. Possible role for vitamin E","volume":"52","year":"1977","journal-title":"Arch Dis Child"},{"key":"key20240108073431_B145","article-title":"Long-term nicotinamide riboside use improves coordination and eye movements in ataxia telangiectasia","year":"2023","journal-title":"Mov Disord"},{"key":"key20240108073431_B146","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"8","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"key20240108073431_B147","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pediatrneurol.2009.07.015","article-title":"Creatine and creatine deficiency syndromes: biochemical and clinical aspects","volume":"42","year":"2010","journal-title":"Pediatr Neurol"},{"issue":"3","key":"key20240108073431_B148","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","article-title":"Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism","volume":"85","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"3","key":"key20240108073431_B149","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10545-012-9517-7","article-title":"Low lysine diet in glutaric aciduria type I\u2013effect on anthropometric and biochemical follow-up parameters","volume":"36","year":"2013","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"key20240108073431_B150","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp.2008.161059","article-title":"The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease","volume":"81","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/835\/65a78078f1bad.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:44:15Z","timestamp":1782816255000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.835\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,8]]}},"alternative-id":["10.5334\/tohm.835"],"URL":"https:\/\/doi.org\/10.5334\/tohm.835","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2"}}